PT-141 vs Kisspeptin-10: Which Sexual Health Peptide Is Better?
Comparing PT-141 (bremelanotide, FDA-approved for HSDD) vs Kisspeptin-10 (hypothalamic neuropeptide) for sexual function and libido research.
PT-141
Bremelanotide
FDA ApprovedKisspeptin-10
Metastin 45-54
Research OnlyPT-141
An FDA-approved melanocortin agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women. Acts centrally via the CNS to increase sexual desire and arousal in both men and women.
Kisspeptin-10
A 10-amino acid neuropeptide that acts as the master regulator of the reproductive hormonal axis by stimulating GnRH release. Supports testosterone, libido, fertility, and sexual health.
Common Questions
Q: Which works faster for sexual desire?
See the full comparison in our detailed guide.
Q: Which is FDA-approved?
See the full comparison in our detailed guide.
Q: What are the side effects of each?
See the full comparison in our detailed guide.
Q: Which is better for men vs women?
See the full comparison in our detailed guide.
Q: How do they compare mechanistically?
See the full comparison in our detailed guide.
Our Verdict
Winner: PT-141 (for acute use); Kisspeptin (for hormonal support)
PT-141 acts within 45-60 minutes centrally via MC4R to increase sexual desire and is FDA-approved for HSDD in women. Kisspeptin works more slowly by stimulating GnRH, testosterone, and LH production — it's better suited for addressing underlying hormonal deficiency rather than acute enhancement.